JPRN-UMIN000027062已完成未知
A study on the effectiveness of USRP002(development code) - A study on the effectiveness of USRP002(development code)
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 59years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1.Subjects who attend a hospital or who take drugs 2.Subjects who are always under the weather 3.Subjects who underwent the surgery of urinary functions 4.Subjects who have had brain spinal cord injury, cystitis, vesicoureteral reflux, ureteral stone, prostatitis, urethritis or prostatic hyperplasia 5.Subjects who have had severe diseases 6.Subjects who participated several blood collections in a day within 3 months 7.Subjects who feel bad by blood collection 8.Subjects who use medical equipment such as pacemaker 9.Subjects who has allergy to medical tapes or electrodes 10.Subjects who participate in the other examinations which have an influence on this examination 11.Subjects deemed inappropriate to participate in this study by the principle investigator
研究者
相似试验
已完成
不适用
A study on the effectiveness of USRP001(development code)Healthy adultsJPRN-UMIN000023443Kao Corporation15
已完成
不适用
A study on the effectiveness of SRRA001(development code)Healthy individuals with relatively-deteriorated sleep healthJPRN-UMIN000025997Kao Corporation32
招募中
2 期
A Phase II Study to Investigate the Efficacy and Safety of Oral intake of Anamorelin in Patients After Total GastrectomyAfter Total GastrectomyJPRN-jRCTs041230012Bando Etsuro65
进行中（未招募）
2 期
Efficacy and safety of polyglycolic acid sheet for the prevention of infectious complication after laparoscopic surgery for gastric cancerIntraperitoneal infectious complicationsPostoperative ComplicationsJPRN-jRCTs052210188Obama Kazutaka210
进行中（未招募）
1 期
A study assessing the combination of TG4010 and nivolumab with standard treatment in patients with advanced non small cell lung cancer.Stage IIIB-IV non small cell lung cancer (NSCLC)MedDRA version: 20.0Level: LLTClassification code 10025055Term: Lung cancer non-small cell stage IVSystem Organ Class: 100000015841EUCTR2016-005115-41-HUTransgene S.A.39